Hear Jim DiBiasi, 3d Communications'speaking on FDA Advisory Committees.
Effective Preparation for FDA Advisory Committee Meetings
Feb. 4-5, 2014 | Washington D.C.
The EMA Disclosure Mandate – A Shift for Clinical Trial Data Sharing
Amanda Batstone (April 30, 2013)
The EMA recently announced one of the biggest developments around public disclosure and sharing of clinical trials data; the regulatory body set a mandate that companies must publish their clinical trials raw data for public access starting January 1, 2014. Journals will no longer publish the results of clinical trials unless drug companies agree to provide raw study data (not just summary data) on request to third party researchers/investigators.
Related Conferences: CBI's 8th Global Forum on Clinical Trial Registries, CBI's 2nd Annual Forum on Global Publication Planning and Clinical Trial Registries